Showing results (241-250 of 280) with videos related to

Sort By:
Pageof 28
Biochemical Pharmacology|April 14, 2025
Methyl isoeugenol suppresses NLRP3 inflammasome-mediated pyroptosis via activation of Nrf2/NQO1/HO-1 signaling in cerebral ischemia-reperfusion injuryHuina Liu, Weitao Chen, Meiyuan He, et al.
Lasers in Surgery and Medicine|October 2, 2022
Utility of high-resolution ultrasound in measuring subcutaneous fat thicknessNoor Anvery, Hoi Ting Wan, McKenzie A Dirr, et al.
Cancer Cell International|October 21, 2023
The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophagesBaoyue Pan, Ting Wan, Yun Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistanceTing-Wan Kao, Geng-Hao Bai, Tian-Li Wang, et al.
Structure (London, England : 1993)|November 9, 2004
Structures of Selenomonas ruminantium phytase in complex with persulfated phytate: DSP phytase fold and mechanism for sequential substrate hydrolysisHsing-Mao Chu, Rey-Ting Guo, Ting-Wan Lin, et al.
European Journal of Medicinal Chemistry|September 7, 2010
Synthesis and in vitro study of pseudo-peptide thioureas containing α-aminophosphonate moiety as potential antitumor agentsJing-Zi Liu, Bao-An Song, Hui-Tao Fan, et al.
British Journal of Cancer|June 9, 2020
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinomaXue-Tang Mo, Thomas Ho-Yin Leung, Hermit Wai-Man Tang, et al.
Cancer Letters|October 3, 2020
HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancerPeter Kok-Ting Wan, Thomas Ho-Yin Leung, Michelle Kwan-Yee Siu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 1, 2019
The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trialAristine Cheng, Szu-Min Hsieh, Sung-Ching Pan, et al.
Life Sciences|April 1, 2019
Nicotinamide riboside protects against liver fibrosis induced by CCl<sub>4</sub> via regulating the acetylation of Smads signaling pathwayRui Jiang, Yujia Zhou, Sufan Wang, et al.
Pageof 28